Literature DB >> 17379171

A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cells.

Tarek M Fahmy1, Jonathan P Schneck, W Mark Saltzman.   

Abstract

Both monoclonal T cell-specific antibodies and multivalent major histocompatibility complex proteins are used as diagnostic reagents for T cell-mediated diseases. However, their widespread use as vehicles for drug delivery has been hindered by the lack of versatile methods that couple the targeting potential of these reagents with drugs of clinical relevance. To address this problem, we engineered a multivalent nanoscopic drug carrier that flexibly tethers to a variety of T-cell antigens. Our carriers bound their target T cells specifically and with enhanced sensitivities as compared with free antigen. Additionally, they consistently inhibited the proliferation of the target T cells in vitro and in vivo, whereas drug-free constructs elicited strong stimulation of the target populations. As a result of the flexibility of incorporating multivalent antigen and drug, these carriers have wide potential use as sensitive T-cell detection reagents as well as promising immunostimulatory or immunosuppressive tools.

Mesh:

Substances:

Year:  2007        PMID: 17379171     DOI: 10.1016/j.nano.2006.11.010

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  13 in total

Review 1.  Nanosystems for simultaneous imaging and drug delivery to T cells.

Authors:  Tarek M Fahmy; Peter M Fong; Jason Park; Todd Constable; W Mark Saltzman
Journal:  AAPS J       Date:  2007-06-08       Impact factor: 4.009

Review 2.  Cell-mediated drug delivery.

Authors:  Elena V Batrakova; Howard E Gendelman; Alexander V Kabanov
Journal:  Expert Opin Drug Deliv       Date:  2011-02-24       Impact factor: 6.648

3.  Polylactide-cyclosporin A nanoparticles for targeted immunosuppression.

Authors:  Jamil Azzi; Li Tang; Robert Moore; Rong Tong; Najib El Haddad; Takurin Akiyoshi; Bechara Mfarrej; Sunmi Yang; Mollie Jurewicz; Takaharu Ichimura; Neal Lindeman; Jianjun Cheng; Reza Abdi
Journal:  FASEB J       Date:  2010-06-14       Impact factor: 5.191

Review 4.  Engineering nano- and microparticles to tune immunity.

Authors:  James J Moon; Bonnie Huang; Darrell J Irvine
Journal:  Adv Mater       Date:  2012-05-29       Impact factor: 30.849

5.  Tumor cell imaging using the intrinsic emission from PAMAM dendrimer: a case study with HeLa cells.

Authors:  Bijesh K Biswal; Manniledam Kavitha; R S Verma; Edamana Prasad
Journal:  Cytotechnology       Date:  2009-11-12       Impact factor: 2.058

6.  Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16.

Authors:  Rafael Gras; Luis Almonacid; Paula Ortega; Maria J Serramia; Rafael Gomez; F Javier de la Mata; Luis A Lopez-Fernandez; M Angeles Muñoz-Fernandez
Journal:  Pharm Res       Date:  2008-11-25       Impact factor: 4.200

7.  Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.

Authors:  Matthias T Stephan; Darrell J Irvine
Journal:  Nano Today       Date:  2011-06-01       Impact factor: 20.722

Review 8.  Biomaterial Strategies for Immunomodulation.

Authors:  Nathan A Hotaling; Li Tang; Darrell J Irvine; Julia E Babensee
Journal:  Annu Rev Biomed Eng       Date:  2015-09-29       Impact factor: 9.590

Review 9.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

10.  In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes.

Authors:  Yiran Zheng; Matthias T Stephan; S Annie Gai; Wuhbet Abraham; Adrianne Shearer; Darrell J Irvine
Journal:  J Control Release       Date:  2013-06-11       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.